If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

  • This share is currently suspended. It was suspended at a price of 0.4999
  • There is currently no data for NTQ

Licence Agreement with Shell for drilling tech

10 Sep 2019 11:29

RNS Number : 8359L
Enteq Upstream PLC
10 September 2019
 

10 September 2019

 

 

 

Enteq Upstream plc

("Enteq"")

 

 

Licence Agreement with Shell for drilling technology

 

Enteq, the oilfield services technology and equipment supplier, is pleased to announce that on 10 September 2019 it jointly signed a license agreement with Shell Global Solutions (US) Inc. and Shell Global Solutions International, both subsidiaries of Royal Dutch Shell plc ("Shell") (the "Licence"). This Licence gives Enteq exclusive rights to incorporate Shell's patented intellectual property plus other technology (the "Information") into the engineering and manufacture of a specialised Rotary Steerable drilling system.

 

Rotary Steerable systems are becoming a new standard for fast and efficient drilling of oil, gas and geothermal wells. The combination of Shell's Information and Enteq's proven track record of product innovation, engineering and commercialisation offer the potential to produce a "next generation" type of product utilising a novel and unique steering method with potential significant cost reductions and other benefits of operation.

 

The Rotary Steerable drilling market is currently estimated at $1bn within the globally assumed $10bn directional drilling sector for Oil and Gas and expected to grow at 7% CAGR.

 

The Information and License relate to a system that has currently been deployed and tested in an early stage prototype. Enteq envisages that the development of a commercial system will take up to a further two years and may require a total investment of up to approximately $3m over that period, including some initial payments to Shell. Additional expenditure for the subsequent build of trial and commercial inventory would be required and royalty payments will be due to Shell when commercial.

 

Adrian Chesters, Shell General Manager Wells Technology commented "Enteq is a strong licensee and collaborator for this project due to its status as an independent supplier with access to the directional drilling market. Their interest in further developing and commercialising the technology aligns well with our own."

 

Martin Perry, Enteq's Chief Executive Officer commented "The Enteq team has a track record in commercialising innovative engineering projects which have achieved good market share. We look forward to building upon Shell's innovative work to date in order to bring an exciting new product to the directional drilling market."

 

Enteq will issue a trading update on 25th September 2019, ahead of the AGM that will be held later that day.

 

 

 

 

 

For further information, please contact:

 

Enteq Upstream plc +44 (0)149 461 8739

Martin Perry, Chief Executive Officer

David Steel, Finance Director

 

 

Investec Bank plc (NOMAD and Broker) +44 (0)207 597 5970

Chris Treneman, Patrick Robb, David Anderson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRLLFFIARIILIA
Date   Source Headline
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
8th Apr 20217:00 amRNSTrading Statement
10th Mar 202112:12 pmRNSHolding(s) in Company
2nd Mar 202112:14 pmRNSHolding(s) in Company
2nd Mar 20217:00 amRNSLaunch of a new Directional Drilling System
25th Feb 202111:44 amRNSHolding(s) in Company
22nd Feb 20211:27 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSAppointment of a Product Director
23rd Dec 20209:16 amRNSHolding(s) in Company
17th Dec 20203:01 pmRNSChange of Auditor
15th Dec 20204:09 pmRNSIssue of Equity
2nd Dec 202011:21 amRNSIssue of Equity
23rd Nov 20202:21 pmRNSHolding(s) in Company
18th Nov 20205:48 pmRNSInvestor Presentation
18th Nov 20204:25 pmRNSHolding(s) in Company
16th Nov 202012:03 pmRNSDirector/PDMR Shareholding
16th Nov 202011:54 amRNSDirector Shareholding - Correction
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 20203:01 pmRNSHolding(s) in Company
13th Nov 202011:04 amPRNHolding(s) in Company
13th Nov 20207:00 amRNSDirector/PDMR Shareholding
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20203:43 pmRNSDirector/PDMR Shareholding
12th Nov 20202:05 pmRNSSecond Price Monitoring Extn
12th Nov 20202:01 pmRNSPrice Monitoring Extension
12th Nov 202011:06 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSInterim results for the six months
12th Nov 20207:00 amRNSManagement Succession Plan
29th Sep 20202:33 pmRNSResult of AGM
29th Sep 20207:00 amRNSBoard appointment
29th Sep 20207:00 amRNSAGM Trading Statement
20th Aug 202010:06 amRNSDirector/PDMR Shareholding
18th Aug 20207:00 amRNSContract Award
14th Aug 202012:33 pmRNSHolding(s) in Company
31st Jul 202010:27 amRNSDirector/PDMR Shareholding
31st Jul 20209:00 amRNSOne2One Virtual Forum Presentation
28th Jul 20209:05 amRNSReplacement - New Technology Agreement
27th Jul 20202:00 pmRNSNew technology agreement
16th Jul 20203:42 pmRNSIssue of Equity
1st Jul 20207:00 amRNSFinal results for the year ended 31 March 2020
12th Jun 20201:30 pmRNSNotice of Results – Update
11th Jun 20205:17 pmRNSHolding(s) in Company
7th May 20203:31 pmRNSContract Award
7th May 20203:10 pmRNSContract award
5th May 202012:45 pmRNSIssue of Equity
8th Apr 20207:00 amRNSTrading Statement
24th Mar 20205:50 pmRNSBoard changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.